Preventing Posttraumatic Joint contractuRes with Ketotifen 2
common.study.values.description
“PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2”
PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) is a Phase III randomized, controlled, double blinded multicenter trial with 3 parallel groups (Ketotifen 2 mg or 5 mg or lactose placebo twice daily orally for 6 weeks) and a primary endpoint of elbow extension-flexion range of motion (ROM) arc at 12 weeks post-randomization.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Lactose Placebo
One capsule by mouth twice per day
Drug - Ketotifen Fumarate 2mg
2 mg tablets (over-encapsulated into one capsule) by mouth twice per day
Drug - Ketotifen Fumarate 5mg
5 mg tablets (over-encapsulated into one capsule) by mouth twice per day
participant.views.study.view.additional
participant.views.study.view.scientific-title
PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2
common.study.values.clinical-trial-id
NCT03582176
participant.views.study.view.id
eXDxge
